Business2 years ago
Pfizer to acquire sickle cell drugmaker GBT for $5 billion
American drugmaker Pfizer announced a deal on Monday to acquire Global Blood Therapeutics, makers of a recently approved treatment for sickle cell disease, for $5.4 billion....